The methylation status of the Per genes was also linked to increased expression of ERBB2, the gene used to help classify breast cancers by type and a prognostic marker that negatively correlates with disease-free survival and overall survival [108, 109]. The gene discussed is PER1; the disease is breast carcinoma.